Macsart CH 40 Tablet is a combination antihypertensive medication containing Telmisartan 40 mg and Chlorthalidone 12.5 mg. Telmisartan is an angiotensin II receptor blocker (ARB) that selectively inhibits the binding of angiotensin II to the AT1 receptor, thereby reducing vasoconstriction and aldosterone secretion, which leads to decreased blood pressure. Chlorthalidone is a thiazide-like diuretic that promotes the excretion of sodium and water by inhibiting sodium reabsorption in the distal convoluted tubules of the kidneys, contributing to volume reduction and further lowering blood pressure. The synergistic action of these two agents provides effective management of hypertension, reducing the risk of cardiovascular events such as stroke and myocardial infarction. Macsart CH 40 is indicated for patients who require combination therapy to achieve optimal blood pressure control when monotherapy is insufficient. It is essential to monitor renal function, electrolytes, and blood pressure regularly during treatment. Contraindications include hypersensitivity to any component, anuria, and severe renal or hepatic impairment. Caution is advised in patients with electrolyte imbalances or gout. This tablet should be used under medical supervision with appropriate dose adjustments based on clinical response.